Skip to main content

Table 1 Characteristics of 10 patients with lymphangioleiomyomatosis

From: Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?

Pat. ID age* (years) sirolimus therapy (days) presence of angiomyolipoma No. of pregnancies Smoking history No. of pneumothoraces
1 47 218 no 0 no 0
2 39 185 yes 1 no 1
3 28 325 no 0 no 2
4 33 758 no 1 no 1
5 49 749 no 3 no 1
6 39 817 yes 0 no 2
7 48 266 yes 0 yes 0
8 29 191 no 2 yes 3
9 51 295 no 0 no 0
10 58 854 yes 0 yes 0
  1. *at time of enrollment